but poses a threat to all age groups and may lead to more serious respiratory illnesses, such as pneumonia, in the elderly and those who are immunocompromised. "We found that on average ...

Immunocompromised participants were much more likely to have received at least four doses of COVID-19 vaccine than their ...

Noroviruses are increasingly recognized as an important cause of chronic gastroenteritis in immunocompromised patients, as reflected by the growing number of clinical case reports. This review ...

In the immunocompromised group, three patients received episodic treatment only, while the remaining two patients received both episodic and suppressive treatment, one of whom completed 16 weeks ...

For the immunocompromised ... insight into the impact that COVID-19 continues to have on those patient groups across different geographies. As our data shows, vaccination alone is often not ...

Researchers found that people aged 60 and older who are immunocompromised exhibited weaker immune responses to RSV vaccines compared to healthy individuals in the same age group. Both vaccines are ...

Median 4-week preF IgG fold rise was 4.21; 61% of participants achieved seroconversion. (HealthDay News) — For immunocompromised individuals, antibody response to respiratory syncytial virus ...

Researchers from the Johns Hopkins Bloomberg School of Public Health supported the first blood center in the U.S. to be granted full FDA approval to provide convalescent plasma to immunocompromised ...

Trainees from racial and ethnic groups traditionally underrepresented in health ... welcomed to submit an abstract for research related to infectious diseases in the immunocompromised host. The ...

The Training Program in Infectious Diseases in the Immunocompromised Host aims to develop the next generation of physician and postdoctoral scientists with expertise in infectious diseases that ...